metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Portal vein gas secondary to acute non-obstructive gastric dilatation
Información de la revista
Vol. 40. Núm. 10.
Páginas 673-675 (diciembre 2017)
Vol. 40. Núm. 10.
Páginas 673-675 (diciembre 2017)
Scientific letter
Acceso a texto completo
Portal vein gas secondary to acute non-obstructive gastric dilatation
Gas portal secundario a dilatación gástrica aguda no obstructiva
Visitas
1649
Sonia Morales Arteroa,
Autor para correspondencia
soniamoralesa@yahoo.es

Corresponding author.
, Camilo J. Castellón Pavónb, Pablo Cereceda Barberoa, Cristina Pérez Algara, Elena Larraz Moraa
a Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario El Escorial, San Lorenzo de El Escorial, Madrid, Spain
b Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario Infanta Elena, Valdemoro, Madrid, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (1)
Table 1. Published cases of PVG due to non-obstructive AGD.
Texto completo

The presence of portal venous gas (PVG) is a rare radiological finding secondary to a gastrointestinal problem. Management of PVG in the emergency department is challenging. The most common cause is intestinal ischaemia, which is associated with a high mortality rate.1 However, PVG can also occur in patients with diseases which have a more favourable prognosis, such as acute gastric dilatation (AGD).1,2 In these cases, it is difficult to choose the best therapeutic approach, and most clinicians opt for conservative management. We present a case in which conservative management was chosen, and review the literature on non-obstructive AGD with PVG.

The patient was a 47-year-old man with a history of hypertension and personality disorder, with several previous suicide attempts, the last one occurring one week previously involving massive intake of benzodiazepines and gabapentin. He presented at the emergency department due to abdominal pain and diarrhoea lasting 4 days, with no fever or other associated symptoms. The physical examination showed good overall status, with a soft and depressible abdomen, pain in the suprapubic region and both iliac fossae, with no signs of peritoneal irritation. The only finding of note on laboratory tests was 11,300leukocytes/mm3, and slightly elevated C-reactive protein. Stool tests and Clostridium difficile culture were negative. Plain abdominal X-ray showed significant gastric dilatation. Computed tomography (CT) scan showed massive gastric dilatation with intrahepatic portal venous gas, with no evidence of gastric pneumatosis, pneumoperitoneum, free fluid, or intra-abdominal disease (Fig. 1). The patient improved both clinically and analytically after placement of a nasogastric tube. The study was completed with a gastroscopy, which showed gastropathy due to irritation. The biopsy showed mild chronic gastritis. The patient was discharged after 10 days with good overall status, asymptomatic, and with no evidence of portal gas in the follow-up CT scan.

Figure 1.

Abdominal CT: large gastric dilatation with intrahepatic portal gas.

(0.13MB).

PVG was reported for the first time in neonates with enterocolitis in 1955, followed by the first case in adults in 1960.1 Since then, the number of cases reported has increased steadily. The presence of PVG is secondary to different gastrointestinal disorders. The most frequent cause in adults is intestinal ischaemia (43–72%), intra-abdominal abscesses (6–11%), inflammatory bowel disease (8%) or digestive tract dilatation (3–12%).1 The main pathogenic factors associated with PVG are: intestinal mucosa defects, elevated gastrointestinal intraluminal pressure, and the presence of gas-forming bacteria.1–4

Although portal gas can sometimes be detected on a plain abdominal X-ray, the diagnostic technique of choice is CT, which can also evaluate the underlying cause. Radiologically, PVG differs from pneumobilia by the presence of gas in peripheral radicles extending to within 2cm of the liver capsule.3 The presence of PVG has hitherto been considered an ominous sign, although prognosis now depends on the severity of the associated underlying process. A review of 182 patients with PVG found that 46% underwent surgery, with an overall mortality rate of 39%:75% in patients with intestinal ischaemia, and 30% in PVG due to digestive tract dilatation, abscesses and gastric ulcer.1 Other gastric causes of PVG are emphysematous gastritis and acute dilatation. AGD is usually secondary to a gastric obstruction (pyloric stenosis, gastric cancer, volvulus, incarcerated hernia, superior mesenteric artery syndrome). Non-obstructive AGD, however, is very rare, and is usually related to eating disorders (anorexia nervosa, bulimia, psychogenic polyphagia). It has also been described in patients with cerebral palsy, diabetic gastropathy, autonomic neuropathy, alcoholism, multiple trauma, ingestion of caustic substances, tricyclic antidepressants and benzodiazepines, cannabis abuse and postoperative complications of antireflux surgery. It is also associated with oral intake after long periods of postoperative fasting and famine victims. The presence of PVG in patients with AGD is also exceptional, and is usually located exclusively in the portal vein and its intrahepatic branches, not in the region of the mesenteric axis, unlike other intestinal causes of PVG.5

We conducted a review of the literature and obtained a further 10 published cases of PVG exclusively related to non-obstructive AGD (Table 1).2–10 The mean age of patients is 28 years (12–69 years), and there are no significant gender differences (6 men and 5 women). The only common pathogenic factor was elevated intra-abdominal pressure. Treatment was usually conservative (nasogastric tube, nil by mouth and fluid therapy). No cases of gastric perforation were reported, and only 2 patients underwent surgery (18.1%): the first in 1961, when few diagnostic techniques were available. This patient died due to associated haemorrhagic pancreatic necrosis.10 The second case underwent surgery due to diagnostic uncertainty; no intraoperative macroscopic abnormalities were observed.4 For this reason, we believe that exploratory laparotomy should be reserved for cases in which there is a suspicion of associated surgical abdominal disease (severe pancreatitis, ischaemia or intestinal obstruction), signs of peritoneal irritation, or a deteriorating clinical course. The mortality rate was 9%,10 far lower than that reported in historical reviews of PVG cases.

Table 1.

Published cases of PVG due to non-obstructive AGD.

Author (year)  Age (years)  Sex  Pathogenesis  Treatment  Clinical course 
Sisk (1961)  19  Female  Cerebral palsy and haemorrhagic pancreatic necrosis  Surgery  Died 
Dell (1967)  13  Male  Cerebral palsy  Conservative  Survived 
Benson (1985)  22  Female  Cerebral palsy  Conservative  Survived 
Radin (1987)  28  Female  Drug abuse  Conservative  Survived 
Chen (1997)  24  Male  Epileptic crisis  Conservative  Survived 
Parada-González (2004)  69  Male  Chronic corticosteroid therapy Sepsis  Surgery  Survived 
Bani-Hani (2008)  12  Female  Traffic accident  Conservative  Survived 
Gómez Espín (2011)  26  Male  Chronic tricyclic antidepressant therapy  Conservative  Survived 
Ansari (2015)  20  Female  Pica. Acute pancreatitis  Conservative  Survived 
Sevinc (2015)  29  Male  Chronic use of cannabis  Conservative  Survived 
Morales (2016)  47  Male  Massive intake of benzodiazepines  Conservative  Survived 

In conclusion, the presence of PVG secondary to non-obstructive AGD is a very rare radiological finding caused by an unknown pathogenic mechanism. CT scan, which can also rule out other causes of PVG, is the diagnostic technique of choice. Conservative treatment is usually effective and avoids unnecessary surgery. Unlike other causes of PVG, the prognosis is usually very favourable, provided there is no other associated severe abdominal disease.

References
[1]
H. Kinoshita, M. Shinozaki, H. Tanimura, Y. Umemoto, S. Sakaguchi, K. Takifuji, et al.
Clinical features and management of hepatic portal venous gas: four cases reports and cumulative review of the literature.
Arch Surg, 136 (2001), pp. 1410-1414
[2]
M.D. Benson.
Adult survival with intrahepatic portal venous gas secondary to acute gastric dilatation with a review of portal venous gas.
Clin Radiol, 36 (1985), pp. 441-443
[3]
M.M. Sevinc, E. Kinaci, S. Bayrak, A.H. Yardimci, E. Cakar, H. Bektas.
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: chronic use of synthetic cannabinoid.
World J Gastroenterol, 21 (2015), pp. 10704-10708
[4]
E. Parada-González, E. Fernández Rodríguez, J.M. Nuño Vázquez-Garza, S. González Fernández, J.E. Casal Núñez.
Gas en el sistema venoso portal secundario a dilatación gástrica aguda.
Re Esp Enferm Dig, 96 (2004), pp. 227-229
[5]
M.M. Ansari, N. Mushtaq, V. Pateria, I. Ahmad, N. Kulshreshtha.
Gas in hepatic portal veins with gastric massive dilatation and pneumatosis in acute pancreatitis.
J Clin Diagn Res, 9 (2015), pp. PD05-PD07
[6]
K.W. Chen, J.S. Shin, C.H. Chi, L. Cheng.
Seizure: a rare and transient cause of portal venous gas.
Am J Gastroenterol, 92 (1997), pp. 351-352
[7]
D.R. Radin, R.S. Rosen, J.M. Halls.
Acute gastric dilatation: a rare cause of portal venous gas.
Am J Roentgenol, 148 (1987), pp. 279-280
[8]
K.E. Bani-Hani, H.A. Heis.
Iatrogenic gastric dilatation: a rare and transient cause of hepatic-portal venous gas.
Yonsei Med J, 49 (2008), pp. 669-671
[9]
R. Gómez Espin, H. Hallal, S. Chacon, R. Pascual.
Dilatación gástrica aguda secundaria a melitraceno.
RAPD (online), 34 (2011), pp. 155-156
[10]
P.B. Sisk.
Gas in the portal venous system.
Radiology, 77 (1961), pp. 103-106

Please cite this article as: Morales Artero S, Castellón Pavón CJ, Cereceda Barbero P, Pérez Algar C, Larraz Mora E. Gas portal secundario a dilatación gástrica aguda no obstructiva. Gastroenterol Hepatol. 2017;40:673–675.

Copyright © 2016. Elsevier España, S.L.U.. All rights reserved
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos